Your browser doesn't support javascript.
loading
Rapid stromal remodeling by short-term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma.
Steins, Anne; Klaassen, Remy; Jacobs, Igor; Schabel, Matthias C; van Lier, Monique G J T B; Ebbing, Eva A; Hectors, Stefanie J; Tas, Sander W; Maracle, Chrissta X; Punt, Cornelis J A; Siebes, Maria; Bergman, Jacques J G H M; Medema, Jan Paul; Wilmink, Johanna W; Mathot, Ron A A; Strijkers, Gustav J; Bijlsma, Maarten F; van Laarhoven, Hanneke W M.
Afiliación
  • Steins A; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Klaassen R; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Jacobs I; Oncode Institute, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Schabel MC; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • van Lier MGJTB; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Ebbing EA; Department of Biomedical Engineering, Biomedical NMR, Eindhoven, The Netherlands.
  • Hectors SJ; Oncology Solutions, Philips Research, Eindhoven, The Netherlands.
  • Tas SW; Advanced Imaging Research Center, Oregon Health and Science University, Portland, OR, USA.
  • Maracle CX; Department of Biomedical Engineering and Physics, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Punt CJA; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Siebes M; Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bergman JJGHM; Department of Rheumatology and Immunology, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Medema JP; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Wilmink JW; Department of Rheumatology and Immunology, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Mathot RAA; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Strijkers GJ; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • Bijlsma MF; Department of Biomedical Engineering and Physics, Amsterdam UMC, University of Amsterdam, The Netherlands.
  • van Laarhoven HWM; Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, The Netherlands.
Mol Oncol ; 14(4): 704-720, 2020 04.
Article en En | MEDLINE | ID: mdl-31733011
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Inhibidores de la Angiogénesis / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Inhibidores de la Angiogénesis / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos